Wire Stories

Tikehau Capital and Nikko Asset Management Enter Into Advanced Discussion to Form a Strategic Partnership in Asia

  PARIS--(BUSINESS WIRE)--Regulatory News: Tikehau Capital (Paris:TKO), the global alternative asset management group, and Nikko Asset Management, one of Asia’s…

2 years ago

Mitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses

The Lineup includes the world’s first 8-inch polymer wafer for AR glasses TOKYO--(BUSINESS WIRE)--Mitsui Chemicals, Inc. (Tokyo: 4183; President &…

2 years ago

BELFOR Expands Service Portfolio in Thailand with TBCC

BANGKOK--(BUSINESS WIRE)--#BELFOR--BELFOR Thailand, the local arm of the global leader in damage restoration services, is set to diversify its operations…

2 years ago

InnoCare Appoints Xin Fu as Chief Financial Officer

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that…

2 years ago

Lydia AI Expands Reach in Korea Through Strategic Partnerships with Hecto Data and Tobecon

SEOUL, South Korea--(BUSINESS WIRE)--#canada--Lydia AI, a leading Canadian health AI company, is thrilled to announce its strategic collaborations with Hecto…

2 years ago

InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic Dermatitis

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases,…

2 years ago

FARFETCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action…

2 years ago

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled…

2 years ago

CORRECTING and REPLACING Aurora, PTT Station, and Royal Umbrella are among the Winners of the 2023 – 2024 World Branding Awards

LONDON--(BUSINESS WIRE)--#worldbranding--Fourth paragraph, first sentence of release dated December 8, 2023, should read: Winners from Thailand include Thai Life Insurance,…

2 years ago

MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023

HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a KOL-driven online fashion and lifestyle destination in China, today…

2 years ago